StockSelector.com
  Research, Select, & Monitor Monday, July 13, 2020 7:02:47 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Rubius Therapeutics$5.97($.21)(3.40%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Rubius Therapeutics has an overall rank of 6848 out of 7457 stocks based on 3 positive rankings and 7 negative rankings.

Positive Rankings
Low Put/Call
Rubius Therapeutics has a low Put/Call ratio of 0.05 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Rubius Therapeutics is ranked 185.
Oversold Stochastics
Rubius Therapeutics rank is 656
Debt-to-Equity
Rubius Therapeutics rank is 924
Negative Rankings
Down EPS Surprise
Rubius Therapeutics missed the consensus earnings estimate when it last reported quarterly earnings.
10 Day Loss
Rubius Therapeutics rank is 613
Negative ROE
Rubius Therapeutics rank is 616
Negative ROA
Rubius Therapeutics rank is 657
90 Day Loss
Rubius Therapeutics rank is 1130
High vPut/Call
Rubius Therapeutics has a high Put/Call ratio of 0.80 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Rubius Therapeutics is ranked 1186.
Price-to-Book
Rubius Therapeutics rank is 2348







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2020 StockSelector.com. All rights reserved.